Korea Investment Corp’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-65,005
Closed -$1.65M – 767
2022
Q3
$1.65M Buy
65,005
+9,250
+17% +$325K 0.01% 689
2022
Q2
$1.85M Sell
55,755
-1,145
-2% -$48.6K 0.01% 681
2022
Q1
$4.1M Buy
56,900
+6,200
+12% +$447K 0.01% 598
2021
Q4
$4.66M Sell
50,700
-28,800
-36% -$3.44M 0.01% 534
2021
Q3
$10.1M Buy
79,500
+48,200
+154% +$7.02M 0.03% 364
2021
Q2
$5.21M Buy
31,300
+5,500
+21% +$891K 0.01% 519
2021
Q1
$4.69M Sell
25,800
-5,600
-18% -$1.3M 0.01% 508
2020
Q4
$6.28M Buy
31,400
+10,500
+50% +$2.14M 0.02% 440
2020
Q3
$4.58M Buy
20,900
+1,800
+9% +$381K 0.02% 445
2020
Q2
$3.65M Buy
+19,100
New +$3.35M 0.01% 488

Other funds holding TDOC

Korea Investment Corp's TDOC Position: Q4 2022 in Review

Korea Investment Corp sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 65,005 shares — an estimated $1.65M sold.

Korea Investment Corp first reported a position in TDOC in Q2 2020 and held it in 10 quarters. The position peaked at $10.1M in Q3 2021. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Korea Investment Corp reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Korea Investment Corp sold 65,005 Teladoc Health shares in Q4 2022, an estimated $1.65M.
  • Korea Investment Corp first reported a position in Teladoc Health in Q2 2020 and held it in 10 quarters.
  • Korea Investment Corp's Teladoc Health position peaked at $10.1M in Q3 2021.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Korea Investment Corp's 13F filing for Q4 2022, filed 13 Feb 2023.